Abstract
92 - Semaglutide, single-agent therapy causing hyperosmolar hyperglycemic syndrome in a newly diagnosed type 2 diabetes mellitus
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/s0002-9629(24)00145-9
Copy DOIPublication Date: Feb 1, 2024 | |
Citations: 1 |
92 - Semaglutide, single-agent therapy causing hyperosmolar hyperglycemic syndrome in a newly diagnosed type 2 diabetes mellitus
Join us for a 30 min session where you can share your feedback and ask us any queries you have